about
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisRole of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinomaBarrett's oesophagus: from metaplasia to dysplasia and cancerRisk factors for neoplastic progression in Barrett's esophagus[Dysplasia in Barrett's esophagus--intra- and interobserver variability in histopathological diagnosis].Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.Esophageal carcinoma following bariatric procedures.Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.Barrett's oesophagus--a pathologist's view.Factors associated with carcinoma of the oesophagus at Mulago Hospital, UgandaAbsence of Na+/sugar cotransport activity in Barrett's metaplasiaBarrett's esophagus: can biomarkers predict progression to malignancy?Molecular biological challenges in he treatment of esophageal adenocarcinoma.Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.Patients' perception of diagnostic tests in the preoperative assessment of esophageal cancer.Pathology of esophageal cancer and Barrett's esophagus.GI GEMs: genetically engineered mouse models of gastrointestinal diseaseAberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T).Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha.Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.Expression of COX2 and p53 in Rat Esophageal Cancer Induced by Reflux of Duodenal Contents.Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway.Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's EsophagusImmunohistochemical evaluation for P53 and VEGF (Vascular Endothelial Growth Factor) is not prognostic for long term survival in end stage esophageal adenocarcinoma.p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray.An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus.Prevalence of p21 immunohistochemical expression in esophageal adenocarcinoma.
P2860
Q24602426-E36E2FB0-4DB1-453C-B515-AAE236593211Q24632246-8BA5BE4B-8A4E-47D5-986D-D77319938746Q24685867-0735CD28-60DB-4B36-A05A-C00B704EBFACQ27002062-6521F367-5EE4-4B62-8B3E-55CC9A5A7B10Q30842889-20ECA945-651F-4FC7-BC22-09108E5B8699Q33251710-F6BB58FD-B0AC-48E4-9A61-614DD07E935FQ34470231-B1777A5D-2F2D-4095-87A4-282EC68D61FEQ35210012-C8D5465D-CED7-4F01-B729-936C28106CDEQ36696663-1F0BCE96-AEFB-4BCD-83F4-716E2B18693FQ36699514-9DCBE876-8537-4B3D-956A-CB5F2AB52FC7Q36976116-CFE37307-3650-4269-B393-957A77A73289Q37220658-3EC6938C-A582-4D24-90DA-161EB6B59539Q37345836-E54344A7-63E8-4F32-B602-33DE224D49B4Q37345996-C002302D-3785-49A3-8BD4-216F69441086Q37398079-30CD0477-8D71-4305-967E-A100346C0DCCQ37405552-4EECE4E6-6A3E-4565-9E3E-E25E3F08073EQ37747362-A3A0614D-697D-4330-94DD-2675158ECFEDQ37821995-F948E71D-D32E-42C9-868C-40969172EC4CQ39742785-AC605B9F-3AF8-420D-BE07-2768A3A91D69Q40131733-27F2F95D-266A-4107-9D83-953F2BE5D007Q40220702-E2C7DE31-6F95-4E84-8E9C-09F451942CEFQ40304345-022A453B-B4C7-4D88-A0E2-A7065F79D239Q40359646-B0116C85-7F93-4D36-AA0F-79ABEE6C19C3Q40511383-F09F2DF6-7E08-4082-9411-64C341B476A4Q40622178-F5A0368C-A94F-4961-AC26-70CE01CA7055Q41784325-65AA8F93-3C3F-4996-9F1B-2253CACB4CBFQ44781751-4AF49344-4F94-4D30-8E63-C445B6216BD4Q45935010-7BE50FA0-3978-4C6F-8820-F88FB1C8AD8FQ53330769-CABE07DA-0513-4548-AB51-488046273D0DQ53572323-D8363F93-0288-47AE-988D-5B07D8781B9FQ53583547-6B9CE21D-8740-494D-AFA3-CCEF9380DA20
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Molecular biology of Barrett's adenocarcinoma.
@ast
Molecular biology of Barrett's adenocarcinoma.
@en
type
label
Molecular biology of Barrett's adenocarcinoma.
@ast
Molecular biology of Barrett's adenocarcinoma.
@en
prefLabel
Molecular biology of Barrett's adenocarcinoma.
@ast
Molecular biology of Barrett's adenocarcinoma.
@en
P2093
P2860
P1433
P1476
Molecular biology of Barrett's adenocarcinoma.
@en
P2093
Dinjens WN
Tilanus HW
Wijnhoven BP
P2860
P304
P356
10.1097/00000658-200103000-00005
P407
P577
2001-03-01T00:00:00Z